12:00 AM
 | 
Nov 04, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

MGN1404: Phase I started

Mologen said the Charite-University Hospital Berlin began a German Phase I trial to evaluate MGN1404 in...

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >